Abstract-Decorin is an extracellular matrix (ECM) proteoglycan that may modify vascular smooth muscle cell (SMC) function by altering the response to growth factors and the accumulation of ECM proteins during vascular injury. To investigate these possibilities in vivo, decorin was overexpressed at the site of arterial injury by cell-mediated gene transfer. Fischer rat SMCs were transduced in vitro with a retroviral construct that contained the bovine decorin gene and were subsequently seeded into injured rat carotid arteries. A species-specific antibody to bovine decorin and polymerase chain reaction primers were used to detect bovine decorin and distinguish it from endogenous rat decorin.
I
ntimal hyperplasia and subsequent arterial stenosis frequently reduce the long-term benefits of therapeutic vascular interventions in patients. The mechanisms leading to the development of neointimal hyperplasia in response to arterial injury involve increased migration, proliferation, and synthesis of the extracellular matrix (ECM) by smooth muscle cells (SMCs). 1, 2 Increased migration and proliferation of SMCs, which occur early after injury, are responsible for the formation of a highly cellular intimal lesion. The intimal lesion continues to expand after cell migration and proliferation cease as a result of ECM synthesis and accumulation. The majority of efforts to inhibit intimal hyperplasia have focused on inhibition of SMC proliferation and migration. However, inhibition of ECM accumulation could also be an effective strategy because the ECM constitutes Ϸ80% of the volume of the intimal lesion after 4 weeks. Moreover, the phenotype and behavior of SMCs are influenced through interactions between ECM receptors at the surface of SMCs and specific ECM ligands. [3] [4] [5] [6] Decorin is a member of the family of small leucine-rich proteoglycans. [7] [8] [9] The core protein of decorin contains 1 dermatan sulfate side chain near the amino terminal of the core protein and 2 independent binding domains for collagen type 1 and transforming growth factor (TGF)-␤ 1 . 10 Decorin was chosen for the present study because it has previously been shown to inhibit TGF-␤ 1 -induced ECM accumulation in a glomerulonephritis model in rats 11 and a lung fibrosis model in rabbits, 12 to inhibit proliferation of various cell types, [13] [14] [15] [16] and to affect collagen fiber formation. 17, 18 In the present study, we used cell-mediated transfer of the decorin gene to achieve local overexpression of bovine decorin in the neointima that develops after balloon injury of the rat carotid artery. We demonstrate that the local overexpression of this ECM molecule reduces intimal thickening in response to
Tissue Preparation and Morphometric Analysis
The rats received 50 mg bromodeoxyuridine (BrdU) subcutaneously 24 hours before they were euthanized. Subsequently, the animals were fixed by perfusion with 10% neutral-buffered formalin at 120 mm Hg pressure, and the BrdU-positive cells were detected with a monoclonal antibody to BrdU (Boehringer-Mannheim). Alternatively, tissue was processed for transmission electron microscopy as described. 22 The morphometric measurements were performed as described previously. 22 Cell density was determined by counting nuclei per high-power field. Histochemical staining for collagen was performed by using Masson's trichrome procedure. 23 
Reverse Transcription-Polymerase Chain Reaction
RNA from injured and uninjured carotid arteries was isolated as described earlier 24 and reverse-transcribed into cDNA by use of Superscript TN II (Life Technologies). A 180-base DNA fragment of bovine decorin cDNA was amplified (forward primer 312, 5Ј AGT GCC AAA AGA CCT TCC 3Ј, 329; reverse primer 491, 5Ј AGT CGT TCC AAT TTC ACC 3Ј, 474).
Immunocytochemistry
Polyclonal rabbit antisera to the core proteins of mouse decorin (LF-113) and bovine decorin (LF-94) and to the human ␣ 1 (I) c-telopeptide of collagen I (LF-67) were generous gifts of Dr Larry Fisher (National Institute of Dental Research, Bethesda, Md). The rabbit antiserum to human versican was generously provided by Dr Richard Le Baron (University of Texas at San Antonio, San Antonio, Tex). The goat polyclonal antisera to human fibronectin was obtained from ICN Pharmaceuticals Inc. Sections to be stained for the proteoglycan core proteins of decorin and versican were digested with chondroitin ABC lyase (ICN Biomedicals) at 200 mU/mL in 0.1 mol/L Tris-acetate, pH 7.3, for 1 hour at 37°C.
Cell Culture
Aortic SMCs from male Fischer 344 rats were obtained as described previously. 20 Transduced cells were used for experiments between 4 and 8 passages after the initial transduction. After selection by means of the neomycin analogue G418 (800 g/mL), SMCs were maintained in 10% calf serum.
cDNA Probes
The rat versican cDNA probe against the V3 form of SMC versican was obtained from Joan M. Lemire (University of Washington, Seattle). Probes were 32 P-labeled by random priming (Amersham Pharmacia Biotech) by use of 5Ј-(␣-32 P)dCTP. 25 
Statistical Analysis
A Student t test combined with a Welch correction for separate variances was used to determine statistical differences between LXSN-and LDSN-seeded carotid arteries. A value of PϽ0.05 was considered significant.
Results

Low Expression of Decorin in the Intima of Rat Carotid Arteries After Balloon Injury
Balloon injury of left carotid arteries of male Fischer 344 rats was performed, and the animals were euthanized after 1, 2, 4, and 8 weeks. These time periods were chosen because they allowed us to examine the intima at the end of the proliferative and migratory phase (1 and 2 weeks) as well as during the phase of active ECM accumulation (2 to 4 weeks) 1,2 during the response of the vessels to injury. Immunostaining for rat decorin with use of the polyclonal antibody LF-113 ( Figure 1a ) demonstrated that endogenous decorin is predominantly located in the adventitia of uninjured carotid arteries of Fischer 344 rats. After injury, decorin remains in the adventitia with only modest accumulation in the media or intima (Figure 1b to 1d ). Even 8 weeks after balloon injury, decorin accumulation was low in the media and adventitia (not shown). In addition, Northern analysis of decorin mRNA expression was performed at 1, 2, and 4 weeks after injury. For this purpose, the carotid arteries of 3 rats were pooled, and the RNA was isolated. The autoradiograph of the labeled Northern blot and the image of the ethidium bromide-stained RNA gel were scanned and quantified by using NIH image software. The amount of rat decorin mRNA was expressed as the ratio between the signal for rat decorin mRNA and the ethidium bromide-stained rRNA. This procedure resulted in a value for rat decorin expression of 2.2 at 1 week, 2.6 at 2 weeks, and 1.6 at 4 weeks after balloon injury and 2.5 for the uninjured contralateral vessels. Therefore, the present data suggest that decorin is not upregulated during the migratory and proliferative response to injury, nor does it accumulate in the intima at later stages (up to 8 weeks).
Ectopic Expression of Decorin Proteoglycan in Rat SMC In Vitro
Pooled Fischer 344 rat SMCs transduced with the LDSN retrovirus were examined for bovine decorin mRNA and core protein expression. Figure 2B demonstrates the expression of bovine decorin mRNA as determined by use of a speciesspecific DNA probe. Expression of bovine decorin core protein was demonstrated by Western blotting ( Figure 2C ) with a species-specific antibody to bovine decorin (LF-94).
Long-Term Expression of Bovine Decorin in Injured Carotid Arteries After Seeding of LDSN-SMCs
Fischer 344 rat SMCs transduced with the LXSN or LDSN construct were seeded onto the luminal surface of carotid arteries of Fischer 344 rats immediately after balloon injury. The seeded cells adhere to the luminal surface of the denuded vessel and begin to form an intima. 20, 26 Intimas resulting from seeding of LXSN cells demonstrated immunostaining only for rat decorin in the adventitia and minimal accumulation in the intima at 4 weeks after injury ( Figure 3a ). As expected, no staining was observed after the same section was immunostained with the antibody to bovine decorin, LF-94 ( Figure   3b ). Similar results were obtained at 1 and 2 weeks after seeding of LXSN cells (not shown).
The antibody LF-94 to bovine decorin enabled us to discriminate between endogenous rat decorin and the newly introduced bovine decorin. Figure 4A shows a time course of bovine decorin expression in LDSN-seeded vessels. Strong staining for bovine decorin was found in the intima at 1, 2, and 4 weeks after injury, indicating that the cell-mediated transfer of the bovine decorin gene was successful and led to the expression and accumulation of bovine decorin in the intima. At 1 and 2 weeks, accumulation of decorin was also seen in the adventitia. This adventitial accumulation is inherent to the cell-seeding procedure, because at the end of the cell seeding, the excess cells that do not adhere to the internal elastic lamina are flushed into the wound around the vessel. These cells populate the scar tissue and the adventitia. In addition to immunocytochemistry, reverse transcriptionpolymerase chain reaction (PCR) was used to demonstrate mRNA expression of bovine decorin in LDSN-seeded carotid arteries. For this purpose, mRNA of uninjured, LXSNseeded, and LDSN-seeded vessels was isolated 4 weeks after SMC seeding, reverse-transcribed, and subjected to PCR by using bovine-specific primers for a 180-bp sequence of decorin cDNA. The plasmid containing the cDNA for bovine decorin served as positive control. As shown in Figure 4C , no PCR product was obtained from uninjured or LXSN-seeded vessels, whereas a band representing the 180-bp sequence was obtained from the LDSN-seeded vessels. These results, together with the immunostaining for decorin, demonstrate that bovine decorin mRNA and protein are expressed in the LDSN-seeded vessels up to 4 weeks after injury. In addition, we analyzed the expression of rat decorin (LF-113) in the same sections ( Figure 4B ). Rat decorin is confined to the adventitia and does not change in the LDSN cell-seeded carotid arteries.
In addition, it was determined whether the expression of the bovine decorin in Fischer 344 rats gives rise to antibodies against bovine decorin, which could, in turn, neutralize decorin-mediated effects. For this purpose, SMCs overex- pressing bovine decorin were grown in culture, and conditioned medium was used as a source from which bovine decorin was isolated by anion exchange chromatography and ethanol precipitation. Subsequently, these extracts were run on a SDS-polyacrylamide gel and blotted onto a nitrocellulose membrane. This membrane was probed with serum obtained from animals 4 weeks after seeding of LDSN cells and LXSN SMCs. A biotinylated goat anti-rat antibody was used for detection. No signal for bovine decorin was obtained with the serum of rats seeded with LDSN cells, suggesting that no antibodies to bovine decorin were produced for up to 4 weeks after seeding (data not shown).
Reduced Intimal Area and Increased Intimal Cellularity in Injured Carotid Arteries Overexpressing Bovine Decorin
Intimal areas of carotid arteries seeded with LDSN SMCs, compared with LXSN-seeded arteries, were significantly reduced by 35% at 4 weeks (PϽ0.01, Figure 5A ). No significant difference was observed at 2 weeks. To investigate whether a reduction in intimal SMC proliferation might be responsible for the reduced intimal areas by decorin overexpression, the BrdU labeling index was determined at 1 and 2 weeks. At 1 week, the percentage of BrdU-positive cells was 14.4Ϯ0.8% in LXSN cell-seeded intimas versus 12.8Ϯ1% in LDSN cell-seeded intimas (meanϮSEM, nϭ5). At 2 weeks, the percentage of BrdU-positive cells was 3.0Ϯ0.78% in LXSN cell-seeded intimas versus 4.3Ϯ0.9% in LDSN cellseeded intimas (meanϮSEM, nϭ5). These data suggest that intimal SMC proliferation was not affected by overexpression of decorin.
The intimal nuclear density was determined by counting SMC nuclei per high-power field. As shown in Figure 5B , intimal nuclear density was significantly (PϽ0.01) higher in LDSN cell-seeded vessels at 4 weeks compared with LXSN cell-seeded intimas, suggesting that ECM accumulation might be reduced in decorin-overexpressing intimas. The observations that the total numbers of nuclei ( Figure 5C ) were the same in the intimas of LXSN cell-and LDSN cell-seeded vessels but that the intimal area was reduced in 
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LDSN cell-seeded vessels at 4 weeks also indicate that intimal matrix accumulation was impaired by decorin overexpression.
In addition, at 4 weeks after injury, the luminal crosssectional area was significantly increased in the carotid arteries overexpressing decorin (LDSN, 0.18Ϯ0.06 mm 2 ; LXSN, 0.11Ϯ0.03 mm 2 ; nϭ9, meanϮSD).
Decorin Overexpression Induces Alterations in Composition and Organization of Neointimal ECM
The accumulation of fibronectin and versican in intimas of LXSN cell-and LDSN cell-seeded carotid arteries was analyzed by immunostaining. Four weeks after cell seeding, the staining for versican and fibronectin was much less in the LDSN cell-seeded vessels (Figures 6g and 6h ) than in the LXSN cell-seeded vessels (Figures 6c and 6d) . On the other hand, the LDSN cell-seeded intimas showed more pronounced staining for collagen, as shown by immunohistochemistry for collagen type I (Figure 6f ) and by histochemistry using Masson's trichrome stain (Figure 7b) . In most cases, the increased staining for collagen was pronounced at the base of the neointima. Transmission electron microscopy showed these regions to be enriched in collagen fibrils in the decorin-overexpressing neointimas ( Figures 8A and 8B) , whereas fewer collagen fibrils were present in the LXSNseeded vessels ( Figures 8C and 8D ). The ECM in these areas of the LXSN-seeded vessels contained large spaces filled with amorphous electron-dense materials and occasional bundles of collagen fibrils cut in cross section, as well as isolated collagen fibrils cut in longitudinal section ( Figures  8C and 8D ). In contrast, virtually the entire ECM at the base of the neointima in the LDSN-seeded vessels was filled with collagen fibrils cut in cross section, with occasional immature elastic fibers associated with the surface of the neointimal SMCs ( Figures 8A and 8B) . It is of interest that the bulk of the seeded cells was found at the base of the neointima by 1 month after seeding. 20, 22, 26 
Discussion
In the present study, decorin was overexpressed locally in balloon-injured carotid arteries, and the effect of this proteoglycan on intimal hyperplasia, intimal ECM accumulation, and composition was examined. It is of interest that although vascular injury causes increases in a variety of ECM molecules, including several proteoglycans, 27-29 endogenous decorin deposition does not increase, as shown in the present study. The absence of a decorin response after balloon injury makes expression of this proteoglycan a reasonable choice for evaluating the effect of this molecule on the neointimal response. Expression of bovine decorin in the neointima of ballooninjured Fischer 344 rats was accomplished by cell-mediated gene transfer using autologous aortic SMCs that were retrovirally transduced with bovine decorin in vitro. By this method, expression of bovine decorin within the neointima was achieved over the entire experimental period of 4 weeks. The use of the bovine decorin gene provides a clear distinction between endogenous rat decorin and the experimentally introduced bovine decorin by use of the species-specific anti-decorin antibodies LF-113 (rat) and LF-94 (bovine) as well as by use of specific cDNA probes and PCR primers.
Decorin expression caused a significant reduction of intimal area by 35Ϯ4% after 4 weeks. The proliferative response after injury was not affected because the percentage of BrdU-labeled cells and the total cell number per intimal cross section were the same in vector control cell-seeded and decorin cell-seeded intimas. The finding that intimal areas were reduced without a change in total intimal cell number suggests that reduced accumulation of ECM is the mechanism responsible for the inhibition of intimal thickening by decorin. In support of this conclusion, morphometric analysis revealed that the cell density was markedly higher in the decorin cell-seeded intimas after 4 weeks. Although the mechanism by which decorin causes these changes is unknown, a possible explanation could be the inhibition of TGF-␤ 1 activity, in view of the fact that decorin has been reported to inhibit TGF-␤ 1 activity in various models in vitro 30, 31 and in vivo. 11, 12, 32 TGF-␤ 1 is known to be an important component in the regulation of matrix accumulation in response to wound repair [33] [34] [35] [36] and is thought to play a similar role in the response to arterial injury. 37, 38 Decorin does not interfere with the process of TGF-␤ 1 activation. Instead, the core protein of decorin binds and neutralizes the active TGF-␤ 1 molecule. 31, 39 Indeed, although we did not determine TGF-␤ 1 activity in vivo, the induction of versican mRNA by TGF-␤ 1 is markedly inhibited in cultured Fischer 344 rat SMCs that overexpress bovine decorin in vitro (authors' unpublished data, 1999). This observation suggests that retrovirally expressed decorin can inhibit TGF-␤ 1 activity. The finding of reduced intimal versican and fibronectin accumulation in the injured carotid arteries seeded with decorin-overexpressing cells supports the hypothesis that TGF-␤ 1 activity is reduced by decorin because both versican and fibronectin are induced by TGF-␤ 1 and have, among other ECM molecules, been used to document reduced TGF-␤ 1 activity in experimental models of kidney and lung fibrosis. 11, 12, 32 Furthermore, antibodies to TGF-␤ 1 have a similar effect and reduce neointimal hyperplasia by decreasing versican and fibronectin accumulation without affecting cell proliferation after arterial injury in the rat. 38 However, our finding that the neointimas seeded with decorinexpressing cells stain intensely for collagen would argue for an additional TGF-␤ 1 -independent mechanism, because TGF-␤ 1 is known to increase collagen synthesis by arterial SMCs. 40 The reasons for the reduction of ECM volume and the enrichment of collagen fibrils in decorin-overexpressing intimas are not known. Loss of proteoglycans, such as versican, and other ECM proteins, such as fibronectin, may provide space and concentrate other ECM components, such as fibrillar collagen. It is not known whether total intimal collagen content is changed or whether decorin causes a shift in collagen organization. For example, decorin interacts with collagen types I and II. 41 Initially, it was shown that decorin inhibits collagen fibrillogenesis. 42 However, other reports now suggest that decorin can also affect collagen fiber formation and arrangement in various ways. Decorin was recently shown to improve the tensile properties of collagen fibers 43 and to increase fibril diameter 17 in vitro. In vivo, decorin is frequently found to be closely associated with collagen and is thought to control collagen fiber formation and arrangement, in particular, the interfibrillar spacing (for review see Reference 44) . The distance and the thickness of collagen fibers correlate with the amount of closely associated decorin and biglycan in tendons. 45, 46 It also may be that the binding of decorin to collagen inhibits collagen degradation and stabilizes the collagen fibrillar network. For example, decorin is resistant to proteolysis during interleukin-1-stimulated cartilage catabolism, and this resistance has been correlated with the accumulation of type II collagen. 47 Whether decorin influences collagen degradation in blood vessels in response to injury awaits further study. In healthy vascular tissue, decorin is heavily expressed in the adventitia together with type I collagen, whereas its expression in the media is low. Decorin is also found in the vascular lesions in areas enriched in collagen, 48 -51 suggesting that decorin is involved in the formation of dense collagen-rich structures naturally as lesions form.
The change in the nature of the ECM in the injured vessels in response to the overexpression of decorin differs significantly from the change in ECM after vascular injury in animals treated with another glycosaminoglycan, heparin. 52 Infusion of heparin into animals after balloon injury to the carotid artery causes a significant reduction of intimal collagen and elastin and an increase in proteoglycans. Thus, although both molecules decreased intimal thickening in response to vascular injury, they had dramatically different effects on remodeling the ECM. Such differences are likely to lead to different mechanical properties of the formed lesions.
In conclusion, the local overexpression of the proteoglycan decorin in injured carotid arteries may represent a novel gene therapeutic approach to the reduction of intimal thickening by decreasing ECM volume. The reduction of ECM volume involves the loss of molecules that typify the loose provisional ECM, such as versican and fibronectin, and the enrichment of molecules that contribute to a denser ECM, such as fibrillar collagen. Such conversions are typical of ECM changes seen in during wound healing. 53 Whether such changes lead to increased tensile strength of forming lesions and eventually to atherosclerotic plaque stabilization 54, 55 will require further investigation. Original magnification ϫ20 000. Barϭ200 nm. C, ECM in the vector control-seeded intimas has large areas of amorphous material and occasional bundles of collagen fibrils, either cut in cross section (c) or longitudinal section. Original magnification ϫ5000. Barϭ1 m. D, Highmagnification micrograph of the ECM shown in panel C demonstrates the loose amorphous ECM material and occasional longitudinal sections of a few collagen fibrils. Original magnification ϫ20 000. Barϭ200 nm.
